Total Payments
$207.94
2019 Payments
$31.84
Companies
7
Transactions
13
Medicare Patients
3,857
Medicare Billing
$258,104
Payment Breakdown by Category
Food & Beverage$207.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $207.94 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Puma Biotechnology, Inc. | $61.38 | 3 | $0 (2018) |
| EISAI INC. | $36.77 | 2 | $0 (2019) |
| TESARO, Inc. | $36.58 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.66 | 2 | $0 (2018) |
| Incyte Corporation | $14.94 | 1 | $0 (2018) |
| Siemens Medical Solutions USA, Inc. | $12.35 | 1 | $0 (2017) |
| Amgen Inc. | $12.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $31.84 | 2 | EISAI INC. ($17.01) |
| 2018 | $163.75 | 10 | Puma Biotechnology, Inc. ($61.38) |
| 2017 | $12.35 | 1 | Siemens Medical Solutions USA, Inc. ($12.35) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: Hematology/Oncology | ||||||
| 06/06/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Oncology | ||||||
| 05/03/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Oncology | ||||||
| 04/26/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Oncology | ||||||
| 04/19/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Oncology | ||||||
| 06/15/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: DX - Diagnostics incl. all products and services | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,286 | 2,136 | $320,296 | $85,539 |
| 2022 | 12 | 1,267 | 2,302 | $349,043 | $93,923 |
| 2021 | 13 | 442 | 917 | $131,687 | $28,393 |
| 2020 | 16 | 862 | 2,131 | $293,100 | $50,248 |
Total Patients
3,857
Total Services
7,486
Medicare Billing
$258,104
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 164 | 342 | $78,660 | $20,557 | 26.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 281 | 443 | $44,373 | $11,849 | 26.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 171 | 228 | $40,288 | $10,898 | 27.1% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Office | 2023 | 26 | 107 | $31,650 | $8,659 | 27.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 177 | 311 | $31,666 | $7,936 | 25.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 106 | 201 | $20,270 | $4,160 | 20.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 28 | 63 | $11,570 | $3,745 | 32.4% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 25 | 30 | $8,100 | $3,173 | 39.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 40 | 48 | $8,503 | $3,108 | 36.6% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2023 | 24 | 89 | $13,650 | $2,884 | 21.1% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 24 | 26 | $6,420 | $2,857 | 44.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 25 | 37 | $4,477 | $1,675 | 37.4% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 16 | 18 | $3,282 | $1,257 | 38.3% |
| 88363 | Examination of archival tissue for genetic analysis | Office | 2023 | 57 | 57 | $6,840 | $915.08 | 13.4% |
| 88329 | Pathology examination of specimen during surgery | Facility | 2023 | 29 | 29 | $3,190 | $753.71 | 23.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 18 | 22 | $2,660 | $541.53 | 20.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 40 | 46 | $3,680 | $364.72 | 9.9% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 12 | 14 | $392.00 | $126.56 | 32.3% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 23 | 25 | $625.00 | $77.06 | 12.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 184 | 461 | $106,030 | $28,298 | 26.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 195 | 425 | $43,095 | $11,029 | 25.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 241 | 359 | $35,541 | $9,793 | 27.6% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Office | 2022 | 23 | 90 | $27,000 | $7,685 | 28.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 121 | 156 | $28,348 | $7,515 | 26.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 109 | 222 | $22,285 | $4,666 | 20.9% |
About Dr. James Neill, MD
Dr. James Neill, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Brandon, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912987819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Neill, MD has received a total of $207.94 in payments from pharmaceutical and medical device companies, with $31.84 received in 2019. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($207.94).
As a Medicare-enrolled provider, Neill has provided services to 3,857 Medicare beneficiaries, totaling 7,486 services with total Medicare billing of $258,104. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Brandon, MS
- Active Since 01/18/2006
- Last Updated 09/06/2022
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1912987819
Products in Payments
- Nerlynx (Drug) $61.38
- Lenvima (Drug) $36.77
- ZEJULA (Drug) $36.58
- GILOTRIF (Drug) $33.66
- JAKAFI (Drug) $14.94
- Non-Product Specific (Device) $12.35
- Blincyto (Biological) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Brandon
Sophia Sher, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $209.23
Anatomic Pathology & Clinical Pathology $209.23
Dr. Sherif Nasr
Anatomic Pathology & Clinical Pathology — Payments: $44.59
Anatomic Pathology & Clinical Pathology $44.59
David Etter, Md, MD
Anatomic Pathology & Clinical Pathology
Anatomic Pathology & Clinical Pathology